|
Volumn 32, Issue 7, 2000, Pages 1705-1708
|
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
TACROLIMUS;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
ABO BLOOD-GROUP SYSTEM;
ADULT;
CREATININE;
CYCLOSPORINE;
DIABETES MELLITUS;
FEMALE;
GRAFT REJECTION;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
PREVALENCE;
TACROLIMUS;
TIME FACTORS;
|
EID: 0033670736
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01406-8 Document Type: Article |
Times cited : (1)
|
References (3)
|